Plasmid Instability and Loss Depend on Host, Vector, and Conditions

• In a comparison of industrial E. coli expression strains, HMS174(DE3) stopped growing after induction but retained the expression vector, while BL21(DE3) and RV308(DE3) experienced plasmid loss but continued to grow.
• Therefore, if target protein expression slows the growth of plasmid-bearing cells, cells that express less, lose the plasmid, or acquire growth-promoting mutations can accumulate in the culture — this is a plausible mechanism for "poor re-induction" rather than a necessary or heritable effect of IPTG itself.

Protein Toxicity Is a Real but Context-Dependent Risk

• Recombinant protein toxicity in E. coli is a known problem that led to the development of specialized BL21 derivatives like C41(DE3) and C43(DE3) for expressing toxic proteins.
• In a specific BL21(DE3) metabolic engineering model, IPTG combined with a toxic substrate caused significant physiological stress — but this does not generalize to "IPTG is always toxic"; rather, it shows induction conditions can exacerbate an already stressed cellular state.

The Most Precise Conclusion

If parent cells after overnight induction still retain a complete, functional expression plasmid and regulatory elements, and if the subsequent culture has enough generations to recover healthy growth, the progeny can in principle be re-induced with IPTG later in the main culture. However, this approach increases the probability of poor expression, lower yields, and batch-to-batch variability — especially with high-copy plasmids, strong promoters, toxic proteins, prolonged induction at 37°C, or high IPTG concentrations.

Recommended References

1. Mairhofer J, et al. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during recombinant protein production. Microbial Cell Factories. 2013. — Compares growth and plasmid loss after induction across multiple hosts.

2. Tripathi NK, et al. Impact of the Expression System on Recombinant Protein Production in Escherichia coli. 2021. — Discusses the metabolic burden of transcription/translation and expression system trade-offs.

3. Kopp J, et al. Optimizing recombinant protein expression via automated induction profiling in Escherichia coli. 2017. — Shows the importance of IPTG concentration, temperature, and metabolic burden for growth and expression.

4. van Loosdrecht MCM, et al. The Impact of IPTG Induction on Plasmid Stability and Heterologous Protein Production. 2020. — Directly examines the relationship between IPTG induction, cell viability/growth, and plasmid stability.

5. Baneyx F. Recombinant protein expression in Escherichia coli. Current Opinion in Biotechnology. 1999; and later reviews. — Explains that high-copy plasmids, toxic/ growth-slowing foreign genes, and high-density cultivation all increase plasmid loss risk.

6. Mairhofer J, et al. Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3). Microbial Cell Factories. 2015. — An example of IPTG worsening existing cellular stress in a specific system.

7. Saida F. The toxicity of recombinant proteins in Escherichia coli. Applied Microbiology and Biotechnology. 2004. — Review of recombinant protein toxicity and suitable host strains.

For your own experiments, the most convincing way to determine if your batch has truly "lost induction ability" is not theoretical: isolate single colonies from the new culture, confirm antibiotic resistance, perform plasmid restriction digest or sequencing, and run an SDS-PAGE or Western blot under identical induction conditions (same OD, same IPTG) alongside an uninduced seed control.

Plasmid Instability and Loss Depend on Host, Vector, and Conditions

• In a comparison of industrial E. coli expression strains, HMS174(DE3) stopped growing after induction but retained the expression vector, while BL21(DE3) and RV308(DE3) experienced plasmid loss but continued to grow.
• Therefore, if target protein expression slows the growth of plasmid-bearing cells, cells that express less, lose the plasmid, or acquire growth-promoting mutations can accumulate in the culture — this is a plausible mechanism for "poor re-induction" rather than a necessary or heritable effect of IPTG itself.

Protein Toxicity Is a Real but Context-Dependent Risk

• Recombinant protein toxicity in E. coli is a known problem that led to the development of specialized BL21 derivatives like C41(DE3) and C43(DE3) for expressing toxic proteins.
• In a specific BL21(DE3) metabolic engineering model, IPTG combined with a toxic substrate caused significant physiological stress — but this does not generalize to "IPTG is always toxic"; rather, it shows induction conditions can exacerbate an already stressed cellular state.

The Most Precise Conclusion

If parent cells after overnight induction still retain a complete, functional expression plasmid and regulatory elements, and if the subsequent culture has enough generations to recover healthy growth, the progeny can in principle be re-induced with IPTG later in the main culture. However, this approach increases the probability of poor expression, lower yields, and batch-to-batch variability — especially with high-copy plasmids, strong promoters, toxic proteins, prolonged induction at 37°C, or high IPTG concentrations.

Recommended References

1. Mairhofer J, et al. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during recombinant protein production. Microbial Cell Factories. 2013. — Compares growth and plasmid loss after induction across multiple hosts.

2. Tripathi NK, et al. Impact of the Expression System on Recombinant Protein Production in Escherichia coli. 2021. — Discusses the metabolic burden of transcription/translation and expression system trade-offs.

3. Kopp J, et al. Optimizing recombinant protein expression via automated induction profiling in Escherichia coli. 2017. — Shows the importance of IPTG concentration, temperature, and metabolic burden for growth and expression.

4. van Loosdrecht MCM, et al. The Impact of IPTG Induction on Plasmid Stability and Heterologous Protein Production. 2020. — Directly examines the relationship between IPTG induction, cell viability/growth, and plasmid stability.

5. Baneyx F. Recombinant protein expression in Escherichia coli. Current Opinion in Biotechnology. 1999; and later reviews. — Explains that high-copy plasmids, toxic/ growth-slowing foreign genes, and high-density cultivation all increase plasmid loss risk.

6. Mairhofer J, et al. Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3). Microbial Cell Factories. 2015. — An example of IPTG worsening existing cellular stress in a specific system.

7. Saida F. The toxicity of recombinant proteins in Escherichia coli. Applied Microbiology and Biotechnology. 2004. — Review of recombinant protein toxicity and suitable host strains.

For your own experiments, the most convincing way to determine if your batch has truly "lost induction ability" is not theoretical: isolate single colonies from the new culture, confirm antibiotic resistance, perform plasmid restriction digest or sequencing, and run an SDS-PAGE or Western blot under identical induction conditions (same OD, same IPTG) alongside an uninduced seed control.